INTEGRATED DIAGNOSTICS HOLDINGS PLC
(the "Company")
Notification of Transactions by
Persons Discharging Managerial Responsibilities and
Persons Closely Associated with them
The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.
| 1. | Details of PDMR / person closely associated with them ("PCA")
| |||||
| a) | Name | Hena Holdings Ltd | ||||
| 2. | Reason for the notification
| |||||
| a) | Position / status | PCA of Dr Hend El Sherbini, Chief Executive Officer
| ||||
| b) | Initial notification / amendment | Initial Notification
| ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a) | Name | Integrated Diagnostics Holding plc
| ||||
| b) | LEI | 2138007JN9NUWKKTS790 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a) | Description of the financial instrument
Identification Code | IDH Ordinary Shares of $0.25 each
JE00BLKGSR75 | ||||
| b) | Nature of the transaction | Purchase of shares
| ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information
Aggregated volume Price | 1,058,730
USD 0.4889 per share
| ||||
| e) | Date of the transaction | 16 October 2023
| ||||
| f) | Place of the transaction | London Stock Exchange
| ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
